Your browser doesn't support javascript.
loading
Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients.
Crisafulli, Giovanni; Sartore-Bianchi, Andrea; Lazzari, Luca; Pietrantonio, Filippo; Amatu, Alessio; Macagno, Marco; Barault, Ludovic; Cassingena, Andrea; Bartolini, Alice; Luraghi, Paolo; Mauri, Gianluca; Battuello, Paolo; Personeni, Nicola; Zampino, Maria Giulia; Pessei, Valeria; Vitiello, Pietro Paolo; Tosi, Federica; Idotta, Laura; Morano, Federica; Valtorta, Emanuele; Bonoldi, Emanuela; Germano, Giovanni; Di Nicolantonio, Federica; Marsoni, Silvia; Siena, Salvatore; Bardelli, Alberto.
Afiliação
  • Crisafulli G; Department of Oncology, University of Torino, Candiolo, Italy.
  • Sartore-Bianchi A; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • Lazzari L; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Pietrantonio F; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.
  • Amatu A; The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Macagno M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Barault L; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Cassingena A; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • Bartolini A; Department of Oncology, University of Torino, Candiolo, Italy.
  • Luraghi P; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • Mauri G; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Battuello P; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • Personeni N; The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Zampino MG; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.
  • Pessei V; The FIRC Institute of Molecular Oncology, Milan, Italy.
  • Vitiello PP; Department of Oncology, University of Torino, Candiolo, Italy.
  • Tosi F; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Idotta L; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Morano F; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IRCCS, Milan, Italy.
  • Valtorta E; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • Bonoldi E; Department of Oncology, University of Torino, Candiolo, Italy.
  • Germano G; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • Di Nicolantonio F; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Marsoni S; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Siena S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Bardelli A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Cancer Discov ; 12(7): 1656-1675, 2022 07 06.
Article em En | MEDLINE | ID: mdl-35522273
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias Colorretais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias Colorretais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article